 |
| Enter Our Monthly Contest! |
|
Each month, a single Customized Technology Services
(CTS) test will be given away at random.
Enter Now!
|
|
| |
|
PRESS RELEASE
FOR IMMEDIATE RELEASE
CONTACT:
W. Richard Ulmer
(800) 2-INVITRO
http://www.invitrointl.com
INVITRO REPORTS FIRST QUARTER
FINANCIAL RESULTS
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
Three Months Ended December 31,
1997 1996
Revenues $133,000 $259,000
Costs and expenses 191,000 779,000
Loss from operations (58,000) (520,000)
Other income 0 14,000
Net loss $(58,000) $(506,000)
Loss per common share $(0.004) (0.04)
Weighted average common
shares outstanding 14,028,300 14,028,300
Condensed Consolidated Balance Sheet
December 31, September 30,
1997 1997
Cash and cash equivalents $54,000 $54,000
Other current assets 539,000 584,000
Total current assets 593,000 638,000
Noncurrent assets 229,000 255,000
Total assets $822,000 $893,000
Current liabilities $158,000 $169,000
Shareholders' equity 664,000 724,000
Total liabilities & equity $822,000 $893,000
InVitro International
17751 Sky Park East, Suite G
Irvine, CA 92614
800-2-INVITRO (800-246-8487)
949-851-8356 (International callers)
949- 851-4985 Fax
invitro@invitrointl.com
|
|
